Modern Healthcare January 18, 2019
The CMS’ Center for Medicare and Medicaid Innovation Friday announced a new model to try to shrink skyrocketing Medicare Part D drug spending. It also expanded the scope of its so-called value-based insurance design model for Medicare Advantage plans while also rolling it out over all 50 states.
Some aspects of the value-based insurance design model are coming for Obamacare exchanges as well, according to an expert who has been working closely on the policy with the administration.
The strategy for Part D—framed as a step in the Trump administration’s blueprint to lower prescription drug prices—targets the high expenses in the catastrophic phase of the Part D benefit. Patients hit the catastrophic phase once they have spent the...
Today's Sponsors
Today's Sponsor